Subsequently, we found that ALK phosphorylated TOPK at Y74, and inhibiting both ALK and TOPK enhanced the apoptosis of ALK-positive NSCLC cells ex vivo and in vivo. The gene discussed is PBK; the disease is non-small cell lung carcinoma.